TRIB2 and acute myeloid leukemia: Sub-lethally irradiated cohorts of mice were again injected with GFP+  Trib2 AML blasts and, following comparable disease engraftment between groups (Supplementary Fig. 2D), were treated with vehicle, single drugs, or combination for 21 days.